Trials / Completed
CompletedNCT01282281
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder
Prospective Metabolic Monitoring of Youth and Adults With Bipolar Disorder.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Dr. Ayal Schaffer · Academic / Other
- Sex
- All
- Age
- 14 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Background: Most psychotropic medications that are effective in the treatment of Bipolar Disorder (BD) are associated with endocrine-metabolic changes (EMCs). To date, there is no long-term study in BD that has examined specifically the association of inflammation with EMCs in BD. Specific aims: 1) to identify predictors of EMCs among adolescents and adults with BD who are being started on a medication ; 2) to compare change in EMCs in youth and adults treated for BD; 3) to measure change in EMCs associated with use of different medications for BD. Research Design: Participants: 30 adolescents (14-18 years old) with BD and 30 adults (19-65 years old) with BD. Measures: Blood levels of biomarkers that are associated with EMCs will be measured.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-01-01
- Completion
- 2013-09-01
- First posted
- 2011-01-24
- Last updated
- 2014-01-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01282281. Inclusion in this directory is not an endorsement.